Table 4– Effects of continuous positive airway pressure (CPAP) and zonisamide at 24 weeks
CPAPZonisamidep-value
Subjects n1122
Weight kg2.3 (1.0–3.6)-2.7 (-4.1– -1.4)<0.01
BMI kg·m−20.7 (0.3–1.2)-0.8 (-1.2– -0.4)<0.01
Waist/hip ratio-0.007 (-0.021–0.008)-0.003 (-0.015–0.010)ns
Neck circumference cm0.2 (-0.4–0.7 )-1.3 (-1.7– -0.9)<0.01
Sagittal diameter cm0.4 (-0.8–1.5)-1.9 (-3.0– -0.8)0.01
Systolic BP mmHg1.1 (-10.5–12.8)#-5.7 (-13.0–1.5)ns
Diastolic BP mmHg-7.2 (-14.4– -0.1)#-4.0 (-6.9– -1.1)ns
Heart rate beats·min−10.7 (-3.6–5.0)#-2.1 (-4.3–0.1)ns
AHI events·h−1-42.5 (-57.7– -27.3)-8.0 (-15.9– -0.2)<0.01
ODI events·h−1-40.4 (-55.2– -25.5)-8.1 (-15.1– -0.2)<0.01
Apnoea duration s-4.3 (-10.3–1.7)5.9 (0.8–11.0)0.02
Arousal index events·h−1-28.6 (-44.6– -12.7)-5.1 (-13.3–3.2)<0.01
Mean SpO2 %2.8 (0.9–4.7)0.8 (0.2–1.4)0.01
Minimum SpO2 %8.1 (5.1–11.2)2.4 (0.2–4.7)<0.01
T<90%sat %-16.3 (-37.3–4.8)-8.2 (-14.4– -2.1)ns
TST h0.4 (-0.3–1.1)-0.2 (-0.8–0.4)ns
Sleep efficiency %-2.6 (-8.8–3.6)-3.9 (-8.1–0.3)ns
Stage R % of TST5.4 (2.1–8.7)-2.7 (-5.4–0.0)<0.01
Stage N3 % of TST-1.4 (-5.0–2.3)0.1 (-3.1–3.4)ns
ESS score-4.4 (-7.0– -1.7)-0.4 (-2.4–1.5)0.02
FIS score-19.0 (-29.2–8.8)-3.6 (-12.8–5.5)0.04
Zung depression score-4.4 (-8.0– -0.8)2.8 (-1.0–6.6)0.02
Zung anxiety score-3.1 (-5.4– -0.8)0.7 (-2.1–3.4)0.07
Bicarbonate mmol·L−10.7 (0.1–1.3)-2.3 (-3.0– -1.6)<0.01
Creatinine μmol·L−1-0.6 (-5.5–4.2)7.1 (2.6–11.6)0.03
  • Data are presented as mean change (95% CI), unless otherwise stated. CPAP values are not corrected for compliance. BMI: body mass index; BP: blood pressure; AHI: apnoea/hypopnoea index; ODI: oxygen desaturation index; SpO2: arterial oxygen saturation measured by pulse oximetry; T<90%sat: time spent with SpO2 <90%; TST: total sleep time; ESS: Epworth Sleepiness Scale; FIS: Fatigue Impact Scale; ns: nonsignificant (p>0.1). #: n=9.